Literature DB >> 23061422

Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters.

Jairam R Lingappa1, Katherine K Thomas, James P Hughes, Jared M Baeten, Anna Wald, Carey Farquhar, Guy de Bruyn, Kenneth H Fife, Mary S Campbell, Saidi Kapiga, James I Mullins, Connie Celum.   

Abstract

Plasma HIV-1 RNA set point is an important predictor of HIV-1 disease progression. We hypothesized that inoculum size and HIV-1 exposure prior to HIV-1 transmission may modulate set point. We evaluated predictors of set point among 141 African HIV-1 seroconverters and their HIV-1-infected study partners. We compared characteristics of seroconverters and their HIV-1-infected partners and HIV-1 set point. Data were from a clinical trial of genital HSV-2 suppression with acyclovir to reduce HIV-1 transmission in HIV-1 serodiscordant couples with HIV-1 transmission linkage assigned through virus sequencing. Our analysis includes data from all transmissions including those with transmission linkage to the HIV-1-infected "source partner" and those that were not linked to their HIV-1-infected study partner. In multivariable analysis, higher plasma HIV-1 in source partners was associated with higher seroconverter set point ( + 0.44 log10 copies/ml per log(10) source partner plasma HIV-1, p < 0.001). In addition, bacterial vaginosis (BV) among female source partners near the time of infection was associated with higher set point in their male seroconverters ( + 0.49 log(10), p = 0.04). Source partner characteristics associated with lower set point included male circumcision ( - 0.63 log(10), p = 0.03) and assignment to acyclovir ( - 0.44 log10, p = 0.02). The proportion of variation in set point explained by plasma HIV-1 RNA of the source partner, after controlling for other factors, was 0.06. Source partner plasma HIV-1 level is the most significant predictor of seroconverter set point, possibly reflecting characteristics of the transmitted virus. Acyclovir use, BV among women source partners, and circumcision among male source partners may alter the set point by affecting transmitted virus inoculum in the source partners' genital compartment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23061422      PMCID: PMC3537302          DOI: 10.1089/AID.2012.0206

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  50 in total

1.  Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.

Authors:  Beverly E Sha; M Reza Zariffard; Qiong J Wang; Hua Y Chen; James Bremer; Mardge H Cohen; Gregory T Spear
Journal:  J Infect Dis       Date:  2004-12-02       Impact factor: 5.226

2.  Host determinants of HIV-1 control in African Americans.

Authors:  Kimberly Pelak; David B Goldstein; Nicole M Walley; Jacques Fellay; Dongliang Ge; Kevin V Shianna; Curtis Gumbs; Xiaojiang Gao; Jessica M Maia; Kenneth D Cronin; Shehnaz K Hussain; Mary Carrington; Nelson L Michael; Amy C Weintrob
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

3.  Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission.

Authors:  Jared M Baeten; Erin Kahle; Jairam R Lingappa; Robert W Coombs; Sinead Delany-Moretlwe; Edith Nakku-Joloba; Nelly R Mugo; Anna Wald; Lawrence Corey; Deborah Donnell; Mary S Campbell; James I Mullins; Connie Celum
Journal:  Sci Transl Med       Date:  2011-04-06       Impact factor: 17.956

4.  The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.

Authors:  Moira A McMahon; Janet D Siliciano; Jun Lai; Jun O Liu; James T Stivers; Robert F Siliciano; Rahul M Kohli
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

5.  Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: a pilot study.

Authors:  Carla Moreira; Kartik K Venkatesh; Allison DeLong; Tao Liu; Jaclyn Kurpewski; Jessica Ingersoll; Angela M Caliendo; Susan Cu-Uvin
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

6.  Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts.

Authors:  Jenell S Coleman; Jane Hitti; Elizabeth A Bukusi; Christina Mwachari; Angela Muliro; Rosemary Nguti; Reggie Gausman; Sarah Jensen; Dorothy Patton; David Lockhart; Robert Coombs; Craig R Cohen
Journal:  AIDS       Date:  2007-03-30       Impact factor: 4.177

7.  Interpretation of correlations in setpoint viral load in transmitting couples.

Authors:  Christophe Fraser; T Déirdre Hollingsworth
Journal:  AIDS       Date:  2010-10-23       Impact factor: 4.177

8.  Lack of detectable HIV-1-specific CD8(+) T cell responses in Zambian HIV-1-exposed seronegative partners of HIV-1-positive individuals.

Authors:  Marylyn M Addo; Marcus Altfeld; Diana M Brainard; Almas Rathod; Alicja Piechocka-Trocha; Ulgen Fideli; Joseph Mulenga; Erin Shutes; Donna Marie L Alvino; Eric Hunter; Susan A Allen; Bruce D Walker
Journal:  J Infect Dis       Date:  2010-12-09       Impact factor: 5.226

9.  A whole-genome association study of major determinants for host control of HIV-1.

Authors:  Jacques Fellay; Kevin V Shianna; Dongliang Ge; Sara Colombo; Bruno Ledergerber; Mike Weale; Kunlin Zhang; Curtis Gumbs; Antonella Castagna; Andrea Cossarizza; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Patrick Francioli; Simon Mallal; Javier Martinez-Picado; José M Miro; Niels Obel; Jason P Smith; Josiane Wyniger; Patrick Descombes; Stylianos E Antonarakis; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; David B Goldstein
Journal:  Science       Date:  2007-07-19       Impact factor: 47.728

10.  Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.

Authors:  Jairam R Lingappa; Erin Kahle; Nelly Mugo; Andrew Mujugira; Amalia Magaret; Jared Baeten; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; James Kiarie; Carey Farquhar; Grace John Stewart; Joseph Makhema; M Essex; Edwin Were; Kenneth Fife; Guy Debruyn; Glenda Gray; James McIntyre; Rachel Manongi; Saidi Kapiga; David Coetzee; Susan Allen; Mubiana Inambao; Kayitesi Kayitenkore; Etienne Karita; William Kanweka; Sinead Delany; Helen Rees; Bellington Vwalika; Robert W Coombs; Rhoda Morrow; William Whittington; Lawrence Corey; Anna Wald; Connie Celum
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

View more
  16 in total

1.  Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression.

Authors:  Philippe Selhorst; Carina Combrinck; Nonkululeko Ndabambi; Sherazaan D Ismail; Melissa-Rose Abrahams; Miguel Lacerda; Natasha Samsunder; Nigel Garrett; Quarraisha Abdool Karim; Salim S Abdool Karim; Carolyn Williamson
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  HIV risk associated with serum medroxyprogesterone acetate levels among women in East and southern Africa.

Authors:  Renee Heffron; Randy Stalter; Maria Pyra; Kavita Nanda; David W Erikson; Florian Hladik; Steven W Blue; Nicole L Davis; Nelly Mugo; Athena P Kourtis; Jairam R Lingappa; Jared M Baeten
Journal:  AIDS       Date:  2019-03-15       Impact factor: 4.177

3.  HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.

Authors:  Zachary Ende; Martin J Deymier; Daniel T Claiborne; Jessica L Prince; Daniela C Mónaco; William Kilembe; Susan A Allen; Eric Hunter
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

4.  Association between male circumcision and incidence of syphilis in men and women: a prospective study in HIV-1 serodiscordant heterosexual African couples.

Authors:  Jillian Pintye; Jared M Baeten; Lisa E Manhart; Connie Celum; Allan Ronald; Nelly Mugo; Andrew Mujugira; Craig Cohen; Edwin Were; Elizabeth Bukusi; James Kiarie; Renee Heffron
Journal:  Lancet Glob Health       Date:  2014-10-22       Impact factor: 26.763

5.  Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load.

Authors:  Lele Zhao; Chris Wymant; François Blanquart; Tanya Golubchik; Astrid Gall; Margreet Bakker; Daniela Bezemer; Matthew Hall; Swee Hoe Ong; Jan Albert; Norbert Bannert; Jacques Fellay; M Kate Grabowski; Barbara Gunsenheimer-Bartmeyer; Huldrych F Günthard; Pia Kivelä; Roger D Kouyos; Oliver Laeyendecker; Laurence Meyer; Kholoud Porter; Ard van Sighem; Marc van der Valk; Ben Berkhout; Paul Kellam; Marion Cornelissen; Peter Reiss; Christophe Fraser; Luca Ferretti
Journal:  Virus Evol       Date:  2022-03-16

6.  Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa.

Authors:  Romel D Mackelprang; Mary Carrington; Katherine K Thomas; James P Hughes; Jared M Baeten; Anna Wald; Carey Farquhar; Kenneth Fife; Mary S Campbell; Saida Kapiga; Xiaojiang Gao; James I Mullins; Jairam R Lingappa
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  Plasma viral loads during early HIV-1 infection are similar in subtype C- and non-subtype C-infected African seroconverters.

Authors:  Mary S Campbell; Erin M Kahle; Connie Celum; Jairam R Lingappa; Saidi Kapiga; Andrew Mujugira; Nelly R Mugo; Kenneth H Fife; James I Mullins; Jared M Baeten
Journal:  J Infect Dis       Date:  2013-01-11       Impact factor: 5.226

Review 8.  Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective.

Authors:  Katrina Lythgoe; Sebastian Bonhoeffer; Christophe Fraser; Gabriel E Leventhal; George Shirreff; T Déirdre Hollingsworth; Samuel Alizon
Journal:  Science       Date:  2014-03-21       Impact factor: 47.728

9.  Effects of Succinic Acid and Other Microbial Fermentation Products on HIV Expression in Macrophages.

Authors:  Laura S Graham; Laurie Krass; M Reza Zariffard; Gregory T Spear; Paria Mirmonsef
Journal:  Biores Open Access       Date:  2013-10

Review 10.  The natural history of HIV infection.

Authors:  Caroline A Sabin; Jens D Lundgren
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.